The new program provides access to virtual consultations and pharmacy-filled prescriptions for oral minoxidil and finasteride under clinician supervision. Eden, the leading health platform connecting individuals with licensed providers and pharmacies focused on metabolic health, today announced the launch of its clinician-guided Hair Wellness Program. The program enables adults across the U.S. to explore prescription-based […]

Conference call and webcast: today,May 21, 2025, 9:00 am ET Financial Highlights: — In the first quarter of 2025, total revenues were approximately $2.4 million, compared to approximately $4.2 million in the first quarter of 2024. The first quarter of 2024 revenues included license fee payments totaling $3.5 million – $2.5 million from Lavie Bio's

Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, announced today that the company will be participating in two investor conferences in June 2025. https://mma.prnewswire.com/media/2476789/Valvoline_Logo.jpg Baird 2025 Global Consumer, Technology & Services Conference – Fireside Chat Date: Tuesday, June 3, 2025Time: 3:45 p.m. Eastern Time TD Cowen 9th Annual Future of

BOXX Insurance, the original all-in-one cyber insurance and protection company today announced Cyberboxx® Assist, a comprehensive suite of cyber security tools and services designed to help individuals and businesses predict, prevent and respond to cyber threats through risk assessments, compliance tools and 24/7 expert support from real cyber security experts. This brand new offering will

Angela Shim to lead Product Strategy and Development Mike Tuira to lead Institutional Business Capital Group announced the appointment of two new executives to serve the growing needs of its clients across Canada. Angela Shim will be head of product strategy and development and will be a key member of the Canadian executive leadership team.

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire May 21, 2025 VALUE Phase III trial of EscharEx(R) in venous leg ulcers advancing as planned NexoBrid(R) manufacturing expansion on track; full operational capacity expected by year-end 2025 First quarter revenue of $4 million; full-year 2025 revenue guidance reaffirmed at $24 million Conference

NCEW Investment Consultancy Company Limited reaches strategic cooperation with JDL UK to jointly create a new benchmark of the global integrated logistics services GlobeNewswire May 21, 2025 Hong Kong, China, May 21, 2025 (GLOBE NEWSWIRE) — On May 1, 2025, NCEW Investment Consultancy Company Limited (hereinafter referred to as “NCEW Investment”) and JD Logistics UK

GenVivo Highlights Non-Integrating Retroviral Vector Technology with Persistent Payload Expression at the 2025 Retroviruses Meeting GlobeNewswire May 21, 2025 Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene delivery therapy, immunotherapy, and vaccinology. SAN MARINO, Calif., May 21, 2025 (GLOBE NEWSWIRE) — GenVivo, Inc.,

Independent Analysis Confirms HPQ's Pilot-Scale Fumed Silica Production Baghouse-collected fumed silica yield is outperforming initial projections at this pilot stage GlobeNewswire May 21, 2025 MONTREAL, May 21, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company developing next-generation processes for advanced material manufacturing, is

NeurAxis Announces $5.0 Million Registered Direct Offering GlobeNewswire May 21, 2025 CARMEL, Ind., May 21, 2025 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced that it has entered into definitive agreements for the